Author details

Full Name

Yolanda Sanchez

Affiliation

Collegeville

ORCID

Career Start Year

1985

Papers

108

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36724365	NRF2 Activation Reprograms Defects in Oxidative Metabolism to Restore Macrophage Function in Chronic Obstructive Pulmonary Disease.	Am J Respir Crit Care Med	2023
36430366	Fission Yeast Rho1p-GEFs: From Polarity and Cell Wall Synthesis to Genome Stability.	Int J Mol Sci	2022
34575767	The Role of the Cell Integrity Pathway in Septum Assembly in Yeast.	J Fungi (Basel)	2021
34705450	Fragment-Guided Discovery of Pyrazole Carboxylic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2 Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction.	J Med Chem	2021
34666001	Detection of surface forces by the cell-wall mechanosensor Wsc1 in yeast.	Dev Cell	2021
32267199	Tumor microtubes connect pancreatic cancer cells in an Arp2/3 complex-dependent manner.	Mol Biol Cell	2020
33103994	A novel checkpoint pathway controls actomyosin ring constriction trigger in fission yeast.	Elife	2020
30626555	Discovery of a crystalline sulforaphane analog with good solid-state stability and engagement of the Nrf2 pathway in vitro and in vivo.	Bioorg Med Chem	2019
31693904	Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.	Cell Rep	2019
31505685	Scientific Business Abstracts of the 113th Annual Meeting of the Association of Physicians of Great Britain and Ireland.	QJM	2019
30973731	Structure-Activity and Structure-Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein-Protein Interaction.	J Med Chem	2019
31002701	Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel disease.	PLoS One	2019
29533925	Circadian clock component REV-ERBÎ± controls homeostatic regulation of pulmonary inflammation.	J Clin Invest	2018
29617658	Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.	Cell Rep	2018
29547002	Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists.	Am J Respir Crit Care Med	2018
28790194	Characterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2<i>H</i>-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative Stress.	J Pharmacol Exp Ther	2017
28334931	Rgf1p (Rho1p GEF) is required for double-strand break repair in fission yeast.	Nucleic Acids Res	2017
28166733	A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.	BMC Genomics	2017
29662612	Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.	Oncotarget	2017
29095909	Correction: Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes.	PLoS One	2017
28886135	Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes.	PLoS One	2017
26196323	Expanding the p53 regulatory network: LncRNAs take up the challenge.	Biochim Biophys Acta	2016
26934555	Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sites.	Oncotarget	2016
27031670	Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery.	J Med Chem	2016
25780921	Identification and characterization of PERK activators by phenotypic screening and their effects on NRF2 activation.	PLoS One	2015
26574138	Stephen Elledge and the DNA damage response.	DNA Repair (Amst)	2015
25697088	Neuro-otologic manifestations of tuberculosis. "The great imitator".	Am J Otolaryngol	2015
24478458	The checkpoint-dependent nuclear accumulation of Rho1p exchange factor Rgf1p is important for tolerance to chronic replication stress.	Mol Biol Cell	2014
25524025	Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature.	Nat Commun	2014
24947517	The putative exchange factor Gef3p interacts with Rho3p GTPase and the septin ring during cytokinesis in fission yeast.	J Biol Chem	2014
24563904	Analytical approaches for quantification of a Nrf2 pathway activator: overcoming bioanalytical challenges to support a toxicity study.	Analyst	2014
23391415	Long non-coding RNAs: challenges for diagnosis and therapies.	Nucleic Acid Ther	2013
24070194	Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2.	Genome Biol	2013
23825576	Biochemical characterization of Paracoccidioides brasiliensis Î±-1,3-glucanase Agn1p, and its functionality by heterologous Expression in Schizosaccharomyces pombe.	PLoS One	2013
23907979	The fission yeast cell wall stress sensor-like proteins Mtl2 and Wsc1 act by turning on the GTPase Rho1p but act independently of the cell wall integrity pathway.	Microbiologyopen	2013
21697395	Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.	Mol Cancer Ther	2011
22033190	Xenografts in zebrafish embryos as a rapid functional assay for breast cancer stem-like cell identification.	Cell Cycle	2011
21779180	Proteins in the nutrient-sensing and DNA damage checkpoint pathways cooperate to restrain mitotic progression following DNA damage.	PLoS Genet	2011
20078209	Compatibility and stability of ternary admixtures of tramadol, haloperidol, and hyoscine N-butyl bromide: retrospective clinical evaluation.	J Palliat Med	2010
20716966	Deregulated Ras signaling compromises DNA damage checkpoint recovery in S. cerevisiae.	Cell Cycle	2010
20641019	Cell separation and the maintenance of cell integrity during cytokinesis in yeast: the assembly of a septum.	Yeast	2010
20605902	Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.	J Pharmacol Exp Ther	2010
19000667	Serum soluble transferrin receptor concentrations are increased in central obesity. Results from a screening programme for hereditary hemochromatosis in men with hyperferritinemia.	Clin Chim Acta	2009
19720055	Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases.	Chem Biol Interact	2009
19778378	U2OS cells lacking Chk1 undergo aberrant mitosis and fail to activate the spindle checkpoint.	J Cell Mol Med	2009
19411848	Conserved ATRMec1 phosphorylation-independent activation of Chk1 by single amino acid substitution in the GD domain.	Cell Cycle	2009
19189958	Fission yeast rgf2p is a rho1p guanine nucleotide exchange factor required for spore wall maturation and for the maintenance of cell integrity in the absence of rgf1p.	Genetics	2009
18984588	ATRMec1 phosphorylation-independent activation of Chk1 in vivo.	J Biol Chem	2009
19038232	Regulation of genistein-induced differentiation in human acute myeloid leukaemia cells (HL60, NB4) Protein kinase modulation and reactive oxygen species generation.	Biochem Pharmacol	2009
19037094	The Rho1p exchange factor Rgf1p signals upstream from the Pmk1 mitogen-activated protein kinase pathway in fission yeast.	Mol Biol Cell	2009

1 - 50 of 108

Anna Travesa

University of California-San Diego

Career Start Year 2008

Number of shared co-authors 0

Matthew Jessulat

University of Regina

Career Start Year 2006

Number of shared co-authors 0

Clare L Lawrence

School of Pharmacy and Biomedical Sciences, University of Central Lancashire

Career Start Year 2004

Number of shared co-authors 0

Yoshito Kakihara

Niigata University

Career Start Year 2001

Number of shared co-authors 0

Junjie Chen

The University of Texas MD Anderson Cancer Center

Career Start Year 2000

Number of shared co-authors 0

Rachel Toth

University of Dundee

Career Start Year 1999

Number of shared co-authors 0

Amy Hin Yan Tong

University of Toronto

Career Start Year 1999

Number of shared co-authors 1

Aaron Aslanian

Salk Institute for Biological Studies

Career Start Year 1998

Number of shared co-authors 0

Marcus B Smolka

Weill Institute for Cell and Molecular Biology, Cornell University

Career Start Year 1998

Number of shared co-authors 0

Jung-Ae Kim

University of Science and Technology

Career Start Year 1997

Number of shared co-authors 0

Damarys Loew

Institut Curie, PSL Research University

Career Start Year 1996

Number of shared co-authors 0

Chandra L Theesfeld

Lewis-Sigler Institute for Integrative Genomics, Princeton University

Career Start Year 1996

Number of shared co-authors 0

Patrice Menard

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark

Career Start Year 1996

Number of shared co-authors 1

Grant W Brown

University of Toronto, 1 King's College Circle

Career Start Year 1991

Number of shared co-authors 1

David P Toczyski

University of California San Francisco

Career Start Year 1991

Number of shared co-authors 1

Janos Demeter

Stanford University School of Medicine, Center for Clinical Sciences Research

Career Start Year 1991

Number of shared co-authors 1

J??rg B??hler

University College London

Career Start Year 1991

Number of shared co-authors 0

Matthias Peter

Institute of Biochemistry, ETH Zurich

Career Start Year 1989

Number of shared co-authors 1

Ke Zhang

College of Life Science, Zhejiang University

Career Start Year 1989

Number of shared co-authors 0

Nic Jones

Cancer Research United Kingdom Manchester Institute, University of Manchester

Career Start Year 1988

Number of shared co-authors 0

Stephen P Jackson

Mission Therapeutics Ltd. Glenn Berge Building

Career Start Year 1987

Number of shared co-authors 0

Kwang-Lae Hoe

Chungnam National University

Career Start Year 1987

Number of shared co-authors 0

Mike Tyers

Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal

Career Start Year 1986

Number of shared co-authors 1

Hediye Erdjument-Bromage

Neuroscience Institute, NYU Grossman School of Medicine

Career Start Year 1984

Number of shared co-authors 2

Helena Friesen

University of Toronto

Career Start Year 1984

Number of shared co-authors 1

Brenda J Andrews

University of Toronto

Career Start Year 1983

Number of shared co-authors 1

J. Wade Harper

Harvard Medical School

Career Start Year 1981

Number of shared co-authors 2

Curt Wittenberg

The Scripps Research Institute

Career Start Year 1978

Number of shared co-authors 0

Philip Hieter

University of British Columbia

Career Start Year 1974

Number of shared co-authors 1

Paul Russell

The Scripps Research Institute

Career Start Year 1973

Number of shared co-authors 0

row(s) 1 - 30 of 30

Stephen J Elledge

Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School

Co-authored papers 6

Matthew D Wood

Oregon Health & Science University

Co-authored papers 5

Susan Lindquist

Whitehead Institute for Biomedical Research

Co-authored papers 4

Casey S Greene

Dartmouth College Geisel School of Medicine, Princeton University, University of Colorado Anschutz Medical Campus, University of Pennsylvania Perelman School of Medicine

Co-authored papers 4

Casey S Greene

Co-authored papers 4

Robert J Allaway

Geisel School of Medicine, Dartmouth College

Co-authored papers 3

Stephanie J Bouley

Center for Genomic Medicine, Massachusetts General Hospital

Co-authored papers 3

Albert I Ko

Instituto Goncalo Moniz, Yale School of Public Health

Co-authored papers 3